Noticias financieras organizadas para conectar titulares, símbolos, fuente, fecha y sentimiento con tu análisis y operativa.
LNSR
Si escribes ticker, YENOM prioriza ese instrumento. Si lo dejas vacío puedes explorar el feed general o por tema.
finance.yahoo.comPOSITIVO
LENSAR (LNSR) Q2 2026 Earnings Call Transcript
Image source: The Motley Fool. DATE Thursday, August 13, 2026 at 8:30 a.m. ET CALL PARTICIPANTS Chief Executive Officer - Nicholas Curtis Interim Chief Financial Officer - Michael Rossi Investor Relations Adviser - Lee Roth Full Conference…
Key Points Interested in LENSAR, Inc.? Here are five stocks we like better. LENSAR's second-quarter revenue rose 18% to $16.5 million, driven by a 20% increase in recurring revenue to $13.7 million and a 23% increase in procedure revenue.…
LENSAR, Inc. Q2 2026 Earnings Call Summary - Moby Strategic Reset and Operational Performance Our analysts just identified a stock with the potential to be the next Nvidia. Tell us how you invest and we'll show you why it's our #1 pick. Ta…
Is it a Prudent Move to Retain ALC Stock in Your Portfolio Now?
Alcon's ALC new platforms and lenses are gaining adoption. Dry eye momentum is likely to support growth in the upcoming quarters. However, adverse macroeconomic conditions and intense competition may harm the company's operations. In the p…
Image source: The Motley Fool. DATE Friday, May 8, 2026 at 8:30 a.m. ET CALL PARTICIPANTS Chief Executive Officer — Nicholas CurtisChief Financial Officer — Thomas Staab TAKEAWAYS Total Revenue -- $13.4 million, reflecting a 5% decline yea…
Image source: The Motley Fool. DATE Friday, May 8, 2026 at 8:30 a.m. ET CALL PARTICIPANTS Chief Executive Officer — Nicholas Curtis Chief Financial Officer — Thomas Staab Full Conference Call Transcript Nick Curtis, Chief Executive Officer…
Image source: The Motley Fool. Date Friday, May 8, 2026 at 8:30 a.m. ET Call participants Chief Executive Officer — Nicholas CurtisChief Financial Officer — Thomas Staab Need a quote from a Motley Fool analyst? Email pr@fool.com Takeaways…
Image source: The Motley Fool. Date Friday, May 8, 2026 at 8:30 a.m. ET Call participants Chief Executive Officer — Nicholas Curtis Chief Financial Officer — Thomas Staab Need a quote from a Motley Fool analyst? Email pr@fool.com Full Conf…
LENSAR logo Key Points Interested in LENSAR, Inc.? Here are five stocks we like better. Merger termination cleared the way for LENSAR to "carve its own path," with management refocusing on rebuilding commercial momentum for the ALLY femtos…
LENSAR® Reports First Quarter 2026 Results and Provides Business Update
LENSAR, Inc. 7 ALLY Robotic Cataract Laser Systems® (“ALLY System”) Placements in First Quarter 2026; Backlog of 11 ALLY Systems as of March 31, 2026 First Quarter Recurring Revenue was $12.6 million Total Laser Installed Base Climbs to 44…
How The Failed Alcon Deal Is Reframing The LENSAR (LNSR) Story And $10 Upside Potential
Find your next quality investment with Simply Wall St's easy and powerful screener, trusted by over 7 million individual investors worldwide. The updated analyst narrative around LENSAR now centers on a $10 price target that sits above a m…
Cedar Grove Capital Management’s Views on LENSAR (LNSR)
Michigan-based investment advisor Cedar Grove Capital Management recently released its first quarter 2026 investor letter. A copy of the letter can be downloaded here. Cedar Grove Capital Management’s Multi-Strategy Composite posted a -23.…
How The LENSAR (LNSR) Story Is Shifting After The Failed Alcon Deal And Target Reset
Track your investments for FREE with Simply Wall St, the portfolio command center trusted by over 7 million individual investors worldwide. The reset in LENSAR’s fair value price target from $12.50 to $8.50 puts the recent update to the st…
LENSAR, Inc. Q4 2025 Earnings Call Summary - Moby Strategic Pivot and Operational Recovery Management attributes the termination of the Alcon merger to the Federal Trade Commission's intent to enjoin the deal, leading to a mutual pragmatic…
LENSAR logo Key Points Acquisition terminated — $10 million returned: The Alcon deal was mutually ended after FTC pushback, the $10 million merger deposit becomes LENSAR’s cash (bringing reported cash at Dec. 31 to fully available), and ro…
Quant snapshot: J. Jill, AngioDynamics leads strong buys as INmune Bio, Terrestrial Energy lag
Quant rankings for the upcoming earnings calendar show strength concentrated in consumer discretionary and select industrial and health care names, while weakness is more pronounced across health care, technology, and parts of consumer-fac…
This article first appeared on GuruFocus. Beyond Meat (NASDAQ:BYND) and LENSAR (NASDAQ:LNSR) are among the names driving early action Tuesday as stock futures edge lower and oil prices move higher amid ongoing Iran related tensions. LENSAR…
Fed Kicks Off Policy Meeting as US Equity Futures Tread Water Pre-Bell
US equity futures were little changed ahead of Tuesday's opening bell as traders stayed on the sidel PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premium n…
Alcon abandons effort to purchase LENSAR after FTC scrutiny
This story was originally published on MedTech Dive. To receive daily news and insights, subscribe to our free daily MedTech Dive newsletter. Dive Brief: Alcon and LENSAR agreed to call off their merger, Alcon said Monday. Alcon CEO David…
Alcon and LENSAR, Inc. Agree to Terminate Merger Agreement
GENEVA, March 16, 2026--(BUSINESS WIRE)--Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today announced that it has entered into an agreement with LENSAR, Inc. (NASDAQ: LNSR) to terminate…
LENSAR® Announces Termination of Merger Agreement with Alcon Research, LLC
LENSAR, Inc. Company to Report Fourth Quarter Financial Results and Provide Strategic Update on March 31, 2026 ORLANDO, Fla., March 16, 2026 (GLOBE NEWSWIRE) -- LENSAR, Inc. (Nasdaq: LNSR) (“LENSAR” or the “Company”), a global medical tech…
LENSAR® Provides Update on Pending Acquisition by Alcon
ORLANDO, Fla., Feb. 25, 2026 (GLOBE NEWSWIRE) -- LENSAR, Inc. (Nasdaq: LNSR) (“LENSAR” or the “Company”), a global medical technology company focused on advanced robotic laser solutions for the treatment of cataracts, today provided an upd…
LENSAR® Provides Update on Pending Acquisition by Alcon
LENSAR, Inc. ORLANDO, Fla., Feb. 25, 2026 (GLOBE NEWSWIRE) -- LENSAR, Inc. (Nasdaq: LNSR) (“LENSAR” or the “Company”), a global medical technology company focused on advanced robotic laser solutions for the treatment of cataracts, today pr…
* LENSAR press release [https://seekingalpha.com/pr/20296332-lensar-reports-third-quarter-2025-results-and-provides-business-update] (LNSR [https://seekingalpha.com/symbol/LNSR]): Q3 GAAP EPS of -$0.31. * Revenue of $14.32M. MORE ON LENSAR…
LENSAR® Reports Third Quarter 2025 Results and Provides Business Update
LENSAR, Inc. 18 ALLY Robotic Cataract Laser Systems® (“ALLY Systems”) placed in 3Q 2025; Backlog of 18 ALLY Systems pending installation as of September 30, 2025 ALLY installed base grew 77% and total laser installed base grew 20% over 3Q…
LENSAR Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
ORLANDO, Fla., Sept. 02, 2025 (GLOBE NEWSWIRE) -- LENSAR, Inc. (Nasdaq: LNSR) (“LENSAR” or the “Company”) today announced that a majority of the independent members of LENSAR’s board of directors granted three newly-hired non-executive emp…
SpyGlass Pharma Appoints Elizabeth O’Farrell to its Board of Directors
SpyGlass Pharma, Inc. ALISO VIEJO, Calif., Aug. 19, 2025 (GLOBE NEWSWIRE) -- SpyGlass Pharma™, a privately held ophthalmic biotechnology company, today announced the appointment of Elizabeth (Liz) O’Farrell to its Board of Directors as an…
SpyGlass Pharma Appoints Elizabeth O’Farrell to its Board of Directors
ALISO VIEJO, Calif., Aug. 19, 2025 (GLOBE NEWSWIRE) -- SpyGlass Pharma™, a privately held ophthalmic biotechnology company, today announced the appointment of Elizabeth (Liz) O’Farrell to its Board of Directors as an Independent Director a…
LENSAR Reports Second Quarter 2025 Results and Provides Business Update
LENSAR, Inc. 18 ALLY Robotic Cataract Laser Systems™ (“ALLY Systems”) placed in 2Q 2025 with an additional backlog of 18 ALLY Systems pending installation as of June 30, 2025 ALLY installed base grew 107% and total installed base grew 23%…
LENSAR Reports Second Quarter 2025 Results and Provides Business Update
18 ALLY Robotic Cataract Laser Systems™ (“ALLY Systems”) placed in 2Q 2025 with an additional backlog of 18 ALLY Systems pending installation as of June 30, 2025 ALLY installed base grew 107% and total installed base grew 23% over 2Q 2024…
LENSAR Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
ORLANDO, Fla., July 01, 2025 (GLOBE NEWSWIRE) -- LENSAR, Inc. (Nasdaq: LNSR) (“LENSAR” or the “Company”) today announced that a majority of the independent members of LENSAR’s board of directors granted three newly-hired non-executive empl…
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates LNSR, ATAI, ICAD on Behalf of Shareholders
NEW YORK, June 15, 2025 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders…
HAPPY FATHER’S DAY and $HARHOLDER ALERT: The M&A Class Action Firm Continues to Investigate the Merger: SVT, SSBK, LNSR, iCAD
NEW YORK, June 15, 2025 (GLOBE NEWSWIRE) -- Monteverde & Associates PC (the “M&A Class Action Firm”), has recovered millions of dollars for shareholders and is recognized as a Top 50 Firm in the 2024 ISS Securities Class Action Services Re…
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SVT, LNSR, ICAD, SSBK on Behalf of Shareholders
NEW YORK, June 10, 2025 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders…
$TOCKHOLDER ALERT: The M&A Class Action Firm Encourages Shareholders of SVT, SSBK, LNSR, iCAD to Act
NEW YORK, June 09, 2025 (GLOBE NEWSWIRE) -- Monteverde & Associates PC (the “M&A Class Action Firm”), has recovered millions of dollars for shareholders and is recognized as a Top 50 Firm in the 2024 ISS Securities Class Action Services Re…